BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 6865544)

  • 1. [The problem of carrier detection in Duchenne disease].
    Sabriá Leal M
    Med Clin (Barc); 1983 Apr; 80(13):585-6. PubMed ID: 6865544
    [No Abstract]   [Full Text] [Related]  

  • 2. Carrier detection in Duchenne and Becker muscular dystrophy using dinucleotide repeat polymorphisms. A study in Mexican families.
    Arenas D; Coral R; Cisneros B; Peñaloza L; Salamanca F; Kofman S; Mercado R; Méndez J; Martínez C; Montañez C
    Arch Med Res; 1996; 27(2):151-6. PubMed ID: 8696057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological variations of erythrocytes in Duchenne muscular dystrophy and in carrier state.
    Capriotti M; Dellantonio R; Angeleri F; Curatola G; Mazzanti L; Bertoli E; Lenaz G; Leporoni B
    Boll Soc Ital Biol Sper; 1980 Jul; 56(14):1459-64. PubMed ID: 7448043
    [No Abstract]   [Full Text] [Related]  

  • 4. Sporadic Duchenne muscular dystrophy in females; genetic counseling of women with pelvifemoral muscular dystrophy.
    Zellweger H; Ionasescu V; Simpson J
    Helv Paediatr Acta; 1980 Sep; 35(4):343-8. PubMed ID: 7451237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemophilia and Duchenne de Boulogne myopathy. Genetics].
    Battin J; Serville F
    Rev Prat; 1994 Sep; 44(14):1955-60. PubMed ID: 7939289
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis and carrier detection in a Duchenne muscular dystrophy family by multiplex polymerase chain reaction and microsatellite analysis.
    Jongpiputvanich S; Norapucsunton T; Mutirangura A
    J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S15-21. PubMed ID: 9071063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic counseling in Duchenne muscular dystrophy.
    Dennis MR; Bundey S
    Muscle Nerve; 1981; 4(1):81-2. PubMed ID: 7231452
    [No Abstract]   [Full Text] [Related]  

  • 8. A nearest neighbour decision rule for EMG detection of carriers of Duchenne muscular dystrophy.
    Hausmanowa-Petrusewicz I; Wierzbicka M; Jozwik A; Szmidt-Salkowska E; Borkowska J
    Electromyogr Clin Neurophysiol; 1982; 22(6):445-57. PubMed ID: 7140630
    [No Abstract]   [Full Text] [Related]  

  • 9. Discriminant analysis of ribosomal protein synthesis findings in carrier detection of Duchenne muscular dystrophy.
    Ionasescu V; Burmeister L; Hanson J
    Am J Med Genet; 1980; 5(1):5-12. PubMed ID: 7395900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast clones for detection of Duchenne carriers.
    Ionasescu V; Ionasescu R; Searby C
    N Engl J Med; 1983 Jul; 309(1):51-2. PubMed ID: 6574317
    [No Abstract]   [Full Text] [Related]  

  • 11. Perspectives and molecular diagnosis of Duchenne and Becker muscular dystrophies.
    Prior TW
    Clin Lab Med; 1995 Dec; 15(4):927-41. PubMed ID: 8838231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte capping and carrier detection in Duchenne muscular dystrophy.
    Sands ME; Harris R
    Lancet; 1979 Sep; 2(8144):698. PubMed ID: 90790
    [No Abstract]   [Full Text] [Related]  

  • 13. Heteroduplex analysis of the dystrophin gene: application to point mutation and carrier detection.
    Prior TW; Papp AC; Snyder PJ; Sedra MS; Western LM; Bartolo C; Moxley RT; Mendell JR
    Am J Med Genet; 1994 Mar; 50(1):68-73. PubMed ID: 8160755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier detection by microsatellite analysis of Duchenne/Becker muscular dystrophy in Hungarian families.
    Bachrati CZ; Somodi Z; Endreffy E; Kalmár T; Raskó I
    Ann Hum Genet; 1998 Nov; 62(Pt 6):511-20. PubMed ID: 10363129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier detection.
    Edwards JH
    Prog Clin Biol Res; 1982; 103 Pt B():15-23. PubMed ID: 7163218
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular analysis of the Duchenne muscular dystrophy gene in Spanish individuals: deletion detection and familial diagnosis.
    Patiño A; Narbona J; García-Delgado M
    Am J Med Genet; 1995 Nov; 59(2):182-7. PubMed ID: 8588583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duchenne muscular dystrophy. Morphological study of erythrocytes after treatment with L-alpha-lysophosphatidyl-choline in dystrophic patients and in the carrier state.
    Dellantonio R; Capriotti M; Angeleri F; Curatola G; Mazzanti L; Bertoli E; Lenaz G
    Acta Neurol Belg; 1981; 81(4):193-8. PubMed ID: 7293730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne muscular dystrophy carrier detection using logistic discrimination: serum creatine kinase and hemopexin in combination.
    Percy ME; Andrews DF; Thompson MW
    Am J Med Genet; 1981; 8(4):397-409. PubMed ID: 7246612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid DNA haplotyping using a multiplex heteroduplex approach: application to Duchenne muscular dystrophy carrier testing.
    Prior TW; Wenger GD; Papp AC; Snyder PJ; Sedra MS; Bartolo C; Moore JW; Highsmith WE
    Hum Mutat; 1995; 5(3):263-8. PubMed ID: 7599638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.